Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
0:20
Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
1.2K viewsJan 12, 2023
FacebookCNBC
The FDA has approved a highly effective new HIV-prevention medication, Gilead Sciences reported. | NBC News
0:26
The FDA has approved a highly effective new HIV-prevention medication, Gilead Sciences reported. | NBC News
7.2K views10 months ago
FacebookNBC News
COVID-19 patients respond to Gilead drug: report
1:06
COVID-19 patients respond to Gilead drug: report
Apr 17, 2020
YahooReuters Videos
Gilead stock falls on report of HIV prevention cuts
2:11
Gilead stock falls on report of HIV prevention cuts
6.3K viewsMar 19, 2025
YahooYahoo Finance Video
In a critical announcement that brings hope to millions around the world, Gilead Sciences, which is in the midst of critical Phase 3 trials of the drug Remdesivir in coronavirus patients, said that a breakthrough has been achieved. | NDTV
23:12
In a critical announcement that brings hope to millions around the world, Gilead Sciences, which is in the midst of critical Phase 3 trials of the drug Remdesivir in coronavirus patients, said that a breakthrough has been achieved. | NDTV
Apr 29, 2020
FacebookNDTV
Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19
1:16
Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19
Jun 1, 2020
CNBCMeg Tirrell
Gilead CEO Daniel O’Day breaks down new Trodelvy data in breast cancer patients
3:45
Gilead CEO Daniel O’Day breaks down new Trodelvy data in breast cancer patients
Jun 6, 2022
CNBCMeg Tirrell
2:30
Coronavirus patients reportedly responding to Gilead's experimental treatment
Apr 17, 2020
CNBC
2:50
Gilead Sciences CEO on raising full-year guidance due to remdesivir sales
Jan 11, 2021
CNBCMeg Tirrell
0:43
For more than 35 years, Gilead has been at the forefront of tackling some of the world’s greatest public health challenges. We’re committed to delivering innovative therapies and working to improve the lives of patients around the world. #GileadLife | Gilead Sciences
74.5K views1 year ago
FacebookGilead Sciences
Gilead Sciences (GILD) is buying Tubulis after Arcellx and Ouro. How
4 weeks ago
business-news-today.com
3:11
Gilead Sciences posts mixed Q1 results
Apr 24, 2025
Yahoo
2:38
Gilead Sciences earnings top estimates, boosts full-year outlook
10.1K views9 months ago
YahooYahoo Finance Video
FDA approves Gilead's remdesivir, first drug for treating COVID-19
Oct 22, 2020
fox13news.com
Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions
Apr 29, 2025
NBC10 PhiladelphiaDan Mangan,CNBC
Gilead HIV combo of bictegravir & lenacapavir hits phase 3 goal
4 months ago
marketscreener.com
7:07
Gilead Signs Deal to Expand HIV Drug Access in 120 Developing Healthawareness
Nov 14, 2024
humix.com
7:12
Reporter behind Gilead Covid-19 drug story on findings
Apr 17, 2020
CNBC
#gileadnews #hiv | Gilead Sciences | 29 comments
29 viewsFeb 18, 2025
linkedin.com
1:05
At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife | Gilead Sciences
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:46
We’re paving the way for the future pipeline in oncology and inflammation with a new state-of-the-art Research Center that’s under construction. Take a hard hat tour with us to learn what makes the new labs so unique and how it’s part of Gilead’s bigger investment in U.S. manufacturing and R&D capabilities. gilead.inc/3UZtK1Z | Gilead Sciences
178 views8 months ago
FacebookGilead Sciences
0:28
For more than 35 years, we’ve translated cutting-edge science into innovative solutions, advanced our commitment to achieve health equity and delivered life-changing medicines to people all over the world. Explore our newly redesigned website to see the strides we’ve made: https://www.gilead.com/ #GileadLife | Gilead Sciences
110.3K viewsSep 30, 2024
FacebookGilead Sciences
7:15
Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history
3 months ago
CNBC
0:08
We’re digging in and building a future pipeline of medicine right here in the U.S. The groundbreaking of our New Technical Development Center earlier this month is part of our $32 billion investment in technology and R&D site activities. It will rise next to our new Research Center that will open next year. Both projects are part of Gilead’s commitment to domestic-based research that will create approximately $43 billion in value to the U.S. economy through direct capital and jobs creation. Lear
631 views7 months ago
FacebookGilead Sciences
1:00
Truvada, Viread, Atripla, Stribild, Complera Potential Side Effects Many patients taking Truvada, Viread, Atripla, Stribild, or Complera are taking legal action against Gilead Sciences, Inc. If someone who took these drugs suffered harm as a result, we may be able to help. These drugs are compounded with TDF, which has been linked to side effects such as kidney and bone injuries. However, always consult with a physician prior to discontinuing use of any prescribed medication. Baron & Budd has re
370.1K viewsOct 8, 2021
FacebookDrug Injury News
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Aug 18, 2020
marketscreener.com
3:06
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'
2K viewsApr 29, 2020
YouTubeReuters
8:10
HTI HIV Vaccine Update April 2025: Phase II Trial Results & Gilead’s Next Move #HIVTreatmentupdate
3.5K viewsApr 21, 2025
YouTubeHealth Awareness
Gilead CEO on promising study results for remdesivir Covid-19 treatment
Oct 9, 2020
CNBC
1:25
Gilead shares sink as the FDA rejects the company's arthritis drug
4.4K viewsAug 20, 2020
YouTubeCNBC Television
See more